eagle-i Harvard UniversityHarvard University
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Imaging Assessment Criteria for Oncology Clinical Trials

eagle-i ID

http://harvard.eagle-i.net/i/00000151-6327-b1a3-6771-1ce080000000

Resource Type

  1. Analysis service

Properties

  1. Fee for service
    Yes
  2. Resource Description
    3D Volume RECIST 1.0 RECIST 1.1 irRECIST iRECIST mRECIST for HCC mRECIST for Mesothelioma mRECIST (based on irRC) irRC PCWG2 + RECIST 1.0 PCWG2 + RECIST 1.1 PCWG 3 Cheson (1999) Revised Cheson (2007) Lugano (2015) Lymphoma PET SUVmax LYRIC Deauville (PET) IWCLL IWRC IMWG (for multiple myeloma) IPCG (radiological assessment only) ISCL MacDonald RANO RANO1.1 iRANO Choi WHO PET SUV ATL INRC IWWM PERCIST RECIL
  3. Service Provided by
    Tumor Imaging Metrics Core Facility (DF/HCC)
 
RDFRDF
 
Provenance Metadata About This Resource Record
  1. workflow state
    Published
  2. contributor
    genoap (Genoa Polumbo)
  3. created
    2015-12-02T08:50:20.893-06:00
  4. creator
    gbasinsky (Gina Basinsky)
  5. modified
    2020-03-16T12:29:58.046-04:00

Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016